 Overexpression endometrial cancer advanced stage disease Prior studies overexpression occurs third breast ovarian cancers overexpression poor prognosis monoclonal antibody level expression normal malignant endometrium normal endometrial samples glands variation intensity menstrual cycle endometrial adenocarcinomas normal endometrium High expression patients metastatic disease patients disease uterus High expression absence estrogen receptor increased mortality cancer Further studies significance overexpression endometrial cancer